Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1872]
News [4281]
Articles [400]
Editorials [10]
Conferences [107]
elearning [41]
How do we design trials that improve outcome?
Dr Lisa Carey - University of North Carolina, Chapel Hill, USA
How do we design trials that improve outcome? ( Dr Lisa Carey - University of North Carolina, Chapel Hill, USA )
15 May 2013
Breast cancer heterogeneity no barrier to predictive testing
Dr Michał Jarząb - Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland
Breast cancer heterogeneity no barrier to predictive testing ( Dr Michał Jarząb - Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland )
15 May 2013
Single cell sequencing techniques in early and late breast cancer
Dr Nicholas Navin - MD Anderson Cancer Center, Houston, TX, USA
Single cell sequencing techniques in early and late breast cancer ( Dr Nicholas Navin - MD Anderson Cancer Center, Houston, TX, USA )
15 May 2013
Measurement variation influences gene expression profiles of breast cancer
Dr Rosanna Lau - MD Anderson Cancer Center, Houston, TX, USA
Measurement variation influences gene expression profiles of breast cancer ( Dr Rosanna Lau - MD Anderson Cancer Center, Houston, TX, USA )
15 May 2013
The future of PI3K/AKT/mTOR inhibitors in breast cancer
Dr Sara Hurvitz - UCLA Santa Monica Hematology Oncology, USA
The future of PI3K/AKT/mTOR inhibitors in breast cancer ( Dr Sara Hurvitz - UCLA Santa Monica Hematology Oncology, USA )
15 May 2013
Extracellular matrix proteins of stem cell niches promote breast cancer...
Dr Thordur Oskarsson - HI-STEM, Heidelberg, Germany
Extracellular matrix proteins of stem cell niches promote breast cancer metastasis ( Dr Thordur Oskarsson - HI-STEM, Heidelberg, Germany )
15 May 2013
Early effect of PI3K-Akt-mTOR blockade on in vitro 18F-FDG uptake in HER2...
Dr Yanina Dockx - University of Antwerp, Edegem, Belgium
Early effect of PI3K-Akt-mTOR blockade on in vitro 18F-FDG uptake in HER2 breast cancer resistant to trastuzumab ( Dr Yanina Dockx - University of Antwerp, Edegem, Belgium )
15 May 2013
Update on the METABRIC consortium 2000 Breast Cancer Study
Prof Carlos Caldas - University of Cambridge, UK
Update on the METABRIC consortium 2000 Breast Cancer Study ( Prof Carlos Caldas - University of Cambridge, UK )
14 May 2013
The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast...
Prof Charles Perou - University of North Carolina School of Medicine, USA
The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast cancer ( Prof Charles Perou - University of North Carolina School of Medicine, USA )
14 May 2013
Genetic alterations in postmenopausal women with hormone receptor-positive...
Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium
Genetic alterations in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
14 May 2013
Gene expression test distinguishes between breast cancer patients at high or...
Prof Michael Gnant - Medical University of Vienna, Austria
Gene expression test distinguishes between breast cancer patients at high or low risk of late recurrence ( Prof Michael Gnant - Medical University of Vienna, Austria )
14 May 2013
Long-term effectiveness of SERMs for preventing breast cancer
Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Long-term effectiveness of SERMs for preventing breast cancer ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
14 May 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation